Biogen finalizes $900 mln drug kickback settlement, U.S. says
By Nate RaymondBOSTON, Sept 26 (Reuters) - Biogen Inc has finalized a $900 million settlement resolving a whistleblower lawsuit accusing the biotech...
By Nate RaymondBOSTON, Sept 26 (Reuters) - Biogen Inc has finalized a $900 million settlement resolving a whistleblower lawsuit accusing the biotech...